You have 9 free searches left this month | to do more

gm-csf

Gm Csf is a drug used to treat Lymphoma, Neuroblastoma, Breast Cancer, and other conditions. Gm Csf is being actively studied in 21 studies and prior, has been studied in 35.

Top SponsorsTop SitesTop Investigators
M.D. Anderson Cancer CenterBeth Israel Deaconess Medical CenterMark Hall
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer InstituteRita Sanghvi, Mehta
National Cancer Institute (NCI)Memorial Sloan Kettering Cancer CenterArshed A. Quyyumi
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Completed
  • Metastatic Melanoma
  • Louisville, Kentucky
    James Graham Brown Cancer Center
2021-10-22
Oct 22, 2021
N
Active, not recruiting
  • Pediatric Sepsis-induced MODS
  • GM-CSF
  • Los Angeles, California
  • +7 more
2022-02-24
Feb 24, 2022
M
Completed
  • Critical Injury (Trauma) in Children
  • GM-CSF
  • Aurora, Colorado
  • +7 more
2022-02-24
Feb 24, 2022
M
Recruiting
  • Neuroblastoma
  • β-glucan
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2022-03-11
Mar 11, 2022
S
Recruiting
  • Advanced Refractory Solid Tumors
  • Hypofractionated radiotherapy
  • +3 more
  • Beijing, China
  • +15 more
2021-08-30
Aug 30, 2021
E
Recruiting
  • Peripheral Artery Disease (PAD)
  • GM-CSF
  • Placebo
  • Atlanta, Georgia
    Emory University Hospital
2021-10-08
Oct 8, 2021
M
Active, not recruiting
  • Neuroblastoma
  • Hu3F8
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-12-13
Dec 13, 2021
B
Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • GM-CSF
  • +2 more
  • Boston, Massachusetts
  • +3 more
2022-01-25
Jan 25, 2022
M
Active, not recruiting
  • Neuroblastoma (NB)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-10-19
Oct 19, 2021
T
Recruiting
  • Colorectal Neoplasms
  • hypofractionation Radiotherapy
  • +3 more
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
2022-03-28
Mar 28, 2022
N
Not yet recruiting
  • Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome
  • GM-CSF
  • Placebo
  • Little Rock, Arkansas
  • +25 more
2022-03-02
Mar 2, 2022
N
Completed
  • Mantle Cell Lymphoma
  • Lymphoma, Mantle Cell
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-03-24
Mar 24, 2022
M
Recruiting
  • Recurrent Osteosarcoma
  • humanized anti-GD2 antibody
  • GM-CSF
  • Los Angeles, California
  • +2 more
2021-11-18
Nov 18, 2021
M
Completed
  • Melanoma
  • GM-CSF
  • Standard of Care
  • Rochester, Minnesota
    Mayo Clinic in Rochester
2020-01-29
Jan 29, 2020
G
Suspended
  • Glioblastoma
  • Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
  • +4 more
  • Durham, North Carolina
    Duke University Medical Center
2021-09-21
Sep 21, 2021
U
Active, not recruiting
  • Malignant Melanoma
  • Santa Monica, California
  • +3 more
2021-05-20
May 20, 2021
U
Active, not recruiting
  • Glioblastoma
  • Gliosarcoma
  • Orange, California
  • +2 more
2021-07-20
Jul 20, 2021
C
Completed
  • Breast Cancer
  • NeuVax vaccine
  • +2 more
  • Santa Monica, California
  • +23 more
2022-02-28
Feb 28, 2022
I
Recruiting
  • Solid Tumors
  • +2 more
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
2021-07-18
Jul 18, 2021
U
Active, not recruiting
  • Prostate Cancer
  • pTVG-HP
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
2022-02-07
Feb 7, 2022
F
Recruiting
  • NSCLC Stage IV
  • GM-CSF
  • +2 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
2019-09-25
Sep 25, 2019
U
Active, not recruiting
  • Malignant Melanoma
  • Oslo, Norway
    Oslo University Hospital, Radiumhospitalet
2021-05-14
May 14, 2021
S
Active, not recruiting
  • Neuroblastoma
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
2022-01-05
Jan 5, 2022